COVID-19 Infection Clinical Profile, Management, Outcome, and Antibody Response in Kidney Transplant Recipients: A Single Centre Experience
Research Article
[키워드] age
AKI
analyzed
Antibiotics
Antibody Response
Blood
Blood Group
blood urea
clinical
CNI
Confirmed COVID-19 infection
convalescent plasma
COVID-19
Culture
dialysis
doxycycline
experience
Factor
hospitalized patients
ICU care
IgG antibody
inhibitor
interleukin-6
IQR
Ivermectin
Kidney injury
kidney transplant recipient
Laboratory
low molecular weight
management
Material and Method
median value
Mortality
mortality rate
mounted
nonsurvivor
nonsurvivors
not significantly different
outcomes
overall mortality
Patient
PCR
pharmacological management
polymerase chain
positive
presenting
profile
recovered
Remdesivir
reported
response
Result
retrospective
Risk factors
SARS-CoV-2
serum albumin
severity
Significant
statistically significant
steroid
Support
survivor
Survivors
therapy
Tocilizumab
Transplant
Treatment
ventilated patient
Ventilation
was collected
with COVID-19
[DOI] 10.1155/2021/3129411 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/3129411 PMC 바로가기 [Article Type] Research Article